Hologic, Inc.
NOT FOUND
—
2026-04-22 10:12:13
www.hologic.com
NMS: HOLX
Explore Hologic, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
—
Current Price
NOT FOUND
52W High / Low
$76.07 / $51.9
Stock P/E
—
Book Value
$23.51
Dividend Yield
—
ROCE
9.77%
ROE
10.86%
Face Value
—
EPS
—
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
7,070
Beta
0.7
Debt / Equity
48.05
Current Ratio
4.04
Quick Ratio
3.06
Forward P/E
15.64
Price / Sales
4.11
Enterprise Value
$17.12 B
EV / EBITDA
12.68
EV / Revenue
4.15
Rating
Hold
Target Price
$76.67
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Embecta Corp. | $9.6 | 4.08 | $568.51 M | 6.25% | 35.74% | -13.73% | $15.55 / $8.47 | $-10.35 |
| 2. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
| 3. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 4. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 5. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 6. | ResMed Inc. | $224.49 | 22.19 | $32.69 B | 1.06% | 23.58% | 25.68% | $293.81 / $202 | $43.39 |
| 7. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.05 B | 1.05 B | 1.02 B | 1.01 B | 1.02 B | — |
| Operating Profit | 240.9 M | 252.9 M | 260.9 M | 37.9 M | 233.7 M | — |
| Net Profit | 179.1 M | 187.2 M | 194.9 M | -17.4 M | 201 M | — |
| EPS in Rs | 0.8 | 0.84 | 0.87 | -0.08 | 0.9 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.1 B | 4.03 B | 4.03 B | 4.86 B |
| Operating Profit | 785.4 M | 931 M | 761.5 M | 1.63 B |
| Net Profit | 565.7 M | 789.5 M | 456 M | 1.3 B |
| EPS in Rs | 2.53 | 3.54 | 2.04 | 5.83 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 9.01 B | 9.16 B | 9.14 B | 9.07 B |
| Total Liabilities | 3.97 B | 4.03 B | 4.12 B | 4.2 B |
| Equity | 5.05 B | 5.13 B | 5.02 B | 4.88 B |
| Current Assets | 3.67 B | 3.82 B | 4.18 B | 3.86 B |
| Current Liabilities | 977.2 M | 1.04 B | 1.21 B | 937.7 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.06 B | 1.29 B | 1.05 B | 2.13 B |
| Investing CF | -482.7 M | -781 M | -152.1 M | -206.3 M |
| Financing CF | -777.2 M | -1.11 B | -483.2 M | -756 M |
| Free CF | 904.7 M | 1.15 B | 901 M | 2 B |
| Capex | -152.4 M | -140.2 M | -150.2 M | -127.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0% | -17.12% | — | — |
| Earnings Growth % | 73.14% | -64.98% | — | — |
| Profit Margin % | 19.59% | 11.31% | 26.77% | — |
| Operating Margin % | 23.1% | 18.89% | 33.54% | — |
| Gross Margin % | 55.28% | 51.4% | 61.64% | — |
| EBITDA Margin % | 32.16% | 27.56% | 43.46% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.